Clinical Trials Logo

Clinical Trial Summary

This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.


Clinical Trial Description

PRIMARY OBJECTIVE: I. To obtain observational real-life data of patients who choose this non-conventional treatment and to follow their outcomes. OUTLINE: This is an observational study. Patients have their medical records reviewed on study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06387173
Study type Observational
Source Jonsson Comprehensive Cancer Center
Contact Aletta Deranteriassian
Phone (310)206-6114
Email ADeranteriassian@mednet.ucla.edu
Status Recruiting
Phase
Start date January 4, 2024
Completion date January 3, 2099

See also
  Status Clinical Trial Phase
Recruiting NCT05368428 - Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer N/A
Active, not recruiting NCT02212860 - Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy N/A
Terminated NCT02876640 - Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Phase 1
Recruiting NCT05945290 - Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer
Active, not recruiting NCT02167490 - Sentinel Node Vs Observation After Axillary Ultra-souND N/A
Recruiting NCT02889874 - EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer N/A
Active, not recruiting NCT02095743 - Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer Phase 2
Completed NCT03003611 - Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer N/A
Recruiting NCT06113016 - Prevention of Frailty With Fisetin and Exercise (PROFFi) in Breast Cancer Survivors Phase 2
Recruiting NCT05417867 - Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Stage I-III Breast Cancer